BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics

Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...

February 26, 2024 | News

Thermo Fisher Scientific Awards Latest Oncomine Clinical Research Grants to Propel Oncology Advances

Thermo Fisher Scientific has unveiled the latest recipients of its Oncomine Clinical Research Grant, a prestigious accolade dedicated to advancing research...

February 21, 2024 | News

Biocytogen and Gilead Forge Landmark Collaboration to Harness Fully Human Antibody Library for Therapeutic Innovations

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a leading biotechnology company, announced a significant coll...

February 20, 2024 | News

Biointelect and CR2O Partner to Revolutionize Global Life Science Commercialization

Biointelect and CR2O have announced a strategic partnership aimed at delivering comprehensive commercialization solutions. This collaboration marks a miles...

February 15, 2024 | News

GSK Secures License for Elsie Biotechnologies' Cutting-Edge Discovery Platform

Kevin Green, Chief Operating Officer of Elsie Biotechnologies, expressed enthusiasm, stating, "We are pleased that GSK ha...

February 15, 2024 | News

Brii Biosciences Secures Intellectual Property Rights for HBV Treatment from VBI Vaccines

Brii Biosciences Limited ("Brii Bio"), a leader in developing innovative treatments for diseases with significant unmet needs, has announced a strategic ac...

February 14, 2024 | News

William Lin Discusses QIAGEN's Role in Transforming Healthcare in Asia-Pacific with Innovative Molecular Diagnostics

In a significant stride towards enhancing healthcare diagnostics in the Asia-Pacific region, QIAGEN has recently garnered attention with the approval of it...

February 13, 2024 | Interaction

Gilead Sciences Bolsters Liver Portfolio Through Acquisition of CymaBay Therapeutics

Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced today a definitive agreement whereby Gilead will acquire CymaBay for $32.50 ...

February 13, 2024 | News

Cytiva and LevitasBio unite to revolutionize single-cell workflow, fast-tracking therapeutic development

Technologies work together to simplify single-cell workflows, saving time for academic researchers. Combined VIA Extractor and LeviCell system a...

February 12, 2024 | News

Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing for AVITI System

Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, an...

February 07, 2024 | News

SCIEX Enhances High-Throughput Screening with Echo® MS+ System Expansion

The Echo® MS+ system unlocks enhanced high-throughput screening capability by bringing acoustic ejection mass spectrometry (AEMS) approaches to th...

February 02, 2024 | News

Revvity CEO Prahlad Singh Highlights Resilience and Innovation Amidst Industry Challenges in 2023

Revvity, Inc. (NYSE: RVTY) announced robust financial results for Q4 2023 and the full year ending December 31, 2023. Fourth Quarter 2023 Highlights: ...

February 02, 2024 | Company results

Merck Launches Digital Hub in Singapore to Drive Healthcare and Semiconductor Innovations Globally

Hub to drive innovation and research in healthcare and semi-conductor industries with Syntropy™ and Athinia™ platforms Forms a glo...

January 31, 2024 | News

Merck's Strategic Agreement with Heavy Water Board Boosts Local Manufacturing for Deuterated Compounds in India

In a recent interview with BioPharma APAC, Jean Charles Wirth, Executive Vice President of Science & Laboratory Solutions at Merck, sheds light...

January 26, 2024 | Interview

Stay Connected